S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge

H. Toro, J. F. Zhang, Rodrigo A Gallardo, V. L. Van Santen, F. W. Van Ginkel, K. S. Joiner, C. Breedlove

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Protective properties of three distinct infectious bronchitis virus (IBV) Ark Delmarva poultry industry (ArkDPI) S1 proteins encoded from replication-defective recombinant adenovirus vectors were investigated. Using a suboptimal dose of each recombinant virus, we demonstrated that IBV S1 amino acid sequences showing ≥95.8% amino acid identity to the S1 of the challenge strain differed in their ability at conferring protection. Indeed, the S1 sequence of the IBV population previously designated C4 (AdIBVS1.C4), which protected the most poorly, differs from the S1 sequence of population C2 (AdIBVS1.C2), which provided the highest protection, only at amino acid position 56. The fact that a change in one amino acid in this region significantly altered the induction of a protective immune response against this protein provides evidence that the first portion of S1 displays relevant immunoprotective epitopes. Use of an optimal dose of AdIBVS1.C2 effectively protected chickens from clinical signs and significantly reduced viral load after IBV Ark virulent challenge. Moreover, increased numbers of both IgA and IgG IBV-specific antibody secreting lymphocytes were detected in the spleen after challenge. The increased response detected for both IgA and IgG lymphocytes after challenge might be explained by vaccine-induced B memory cells. The fact that a single vaccination with Ad/IBVS1.C2 provides protection against IBV challenge is promising, because Ad-vectored vaccines can be mass delivered by in ovo inoculation using automated in ovo injectors.

Original languageEnglish (US)
Pages (from-to)211-215
Number of pages5
JournalAvian Diseases
Volume58
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Infectious bronchitis virus
Adenoviridae
Population
Amino Acids
Immunoglobulin A
amino acids
lymphocytes
Vaccines
Immunoglobulin G
vaccination
Lymphocytes
vaccines
injectors
poultry industry
Poultry
dosage
viral load
Viral Load
epitopes
Epitopes

Keywords

  • Adenovirus vector
  • Coronavirus
  • IBV
  • Infectious bronchitis virus
  • S1
  • Vaccine

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Food Animals
  • Immunology and Microbiology(all)

Cite this

Toro, H., Zhang, J. F., Gallardo, R. A., Van Santen, V. L., Van Ginkel, F. W., Joiner, K. S., & Breedlove, C. (2014). S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge. Avian Diseases, 58(2), 211-215. https://doi.org/10.1637/10670-091913

S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge. / Toro, H.; Zhang, J. F.; Gallardo, Rodrigo A; Van Santen, V. L.; Van Ginkel, F. W.; Joiner, K. S.; Breedlove, C.

In: Avian Diseases, Vol. 58, No. 2, 2014, p. 211-215.

Research output: Contribution to journalArticle

Toro, H, Zhang, JF, Gallardo, RA, Van Santen, VL, Van Ginkel, FW, Joiner, KS & Breedlove, C 2014, 'S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge', Avian Diseases, vol. 58, no. 2, pp. 211-215. https://doi.org/10.1637/10670-091913
Toro, H. ; Zhang, J. F. ; Gallardo, Rodrigo A ; Van Santen, V. L. ; Van Ginkel, F. W. ; Joiner, K. S. ; Breedlove, C. / S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge. In: Avian Diseases. 2014 ; Vol. 58, No. 2. pp. 211-215.
@article{843869e21eb24117a6742f401b5cad71,
title = "S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge",
abstract = "Protective properties of three distinct infectious bronchitis virus (IBV) Ark Delmarva poultry industry (ArkDPI) S1 proteins encoded from replication-defective recombinant adenovirus vectors were investigated. Using a suboptimal dose of each recombinant virus, we demonstrated that IBV S1 amino acid sequences showing ≥95.8{\%} amino acid identity to the S1 of the challenge strain differed in their ability at conferring protection. Indeed, the S1 sequence of the IBV population previously designated C4 (AdIBVS1.C4), which protected the most poorly, differs from the S1 sequence of population C2 (AdIBVS1.C2), which provided the highest protection, only at amino acid position 56. The fact that a change in one amino acid in this region significantly altered the induction of a protective immune response against this protein provides evidence that the first portion of S1 displays relevant immunoprotective epitopes. Use of an optimal dose of AdIBVS1.C2 effectively protected chickens from clinical signs and significantly reduced viral load after IBV Ark virulent challenge. Moreover, increased numbers of both IgA and IgG IBV-specific antibody secreting lymphocytes were detected in the spleen after challenge. The increased response detected for both IgA and IgG lymphocytes after challenge might be explained by vaccine-induced B memory cells. The fact that a single vaccination with Ad/IBVS1.C2 provides protection against IBV challenge is promising, because Ad-vectored vaccines can be mass delivered by in ovo inoculation using automated in ovo injectors.",
keywords = "Adenovirus vector, Coronavirus, IBV, Infectious bronchitis virus, S1, Vaccine",
author = "H. Toro and Zhang, {J. F.} and Gallardo, {Rodrigo A} and {Van Santen}, {V. L.} and {Van Ginkel}, {F. W.} and Joiner, {K. S.} and C. Breedlove",
year = "2014",
doi = "10.1637/10670-091913",
language = "English (US)",
volume = "58",
pages = "211--215",
journal = "Avian Diseases",
issn = "0005-2086",
publisher = "American Association of Avian Pathologists",
number = "2",

}

TY - JOUR

T1 - S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge

AU - Toro, H.

AU - Zhang, J. F.

AU - Gallardo, Rodrigo A

AU - Van Santen, V. L.

AU - Van Ginkel, F. W.

AU - Joiner, K. S.

AU - Breedlove, C.

PY - 2014

Y1 - 2014

N2 - Protective properties of three distinct infectious bronchitis virus (IBV) Ark Delmarva poultry industry (ArkDPI) S1 proteins encoded from replication-defective recombinant adenovirus vectors were investigated. Using a suboptimal dose of each recombinant virus, we demonstrated that IBV S1 amino acid sequences showing ≥95.8% amino acid identity to the S1 of the challenge strain differed in their ability at conferring protection. Indeed, the S1 sequence of the IBV population previously designated C4 (AdIBVS1.C4), which protected the most poorly, differs from the S1 sequence of population C2 (AdIBVS1.C2), which provided the highest protection, only at amino acid position 56. The fact that a change in one amino acid in this region significantly altered the induction of a protective immune response against this protein provides evidence that the first portion of S1 displays relevant immunoprotective epitopes. Use of an optimal dose of AdIBVS1.C2 effectively protected chickens from clinical signs and significantly reduced viral load after IBV Ark virulent challenge. Moreover, increased numbers of both IgA and IgG IBV-specific antibody secreting lymphocytes were detected in the spleen after challenge. The increased response detected for both IgA and IgG lymphocytes after challenge might be explained by vaccine-induced B memory cells. The fact that a single vaccination with Ad/IBVS1.C2 provides protection against IBV challenge is promising, because Ad-vectored vaccines can be mass delivered by in ovo inoculation using automated in ovo injectors.

AB - Protective properties of three distinct infectious bronchitis virus (IBV) Ark Delmarva poultry industry (ArkDPI) S1 proteins encoded from replication-defective recombinant adenovirus vectors were investigated. Using a suboptimal dose of each recombinant virus, we demonstrated that IBV S1 amino acid sequences showing ≥95.8% amino acid identity to the S1 of the challenge strain differed in their ability at conferring protection. Indeed, the S1 sequence of the IBV population previously designated C4 (AdIBVS1.C4), which protected the most poorly, differs from the S1 sequence of population C2 (AdIBVS1.C2), which provided the highest protection, only at amino acid position 56. The fact that a change in one amino acid in this region significantly altered the induction of a protective immune response against this protein provides evidence that the first portion of S1 displays relevant immunoprotective epitopes. Use of an optimal dose of AdIBVS1.C2 effectively protected chickens from clinical signs and significantly reduced viral load after IBV Ark virulent challenge. Moreover, increased numbers of both IgA and IgG IBV-specific antibody secreting lymphocytes were detected in the spleen after challenge. The increased response detected for both IgA and IgG lymphocytes after challenge might be explained by vaccine-induced B memory cells. The fact that a single vaccination with Ad/IBVS1.C2 provides protection against IBV challenge is promising, because Ad-vectored vaccines can be mass delivered by in ovo inoculation using automated in ovo injectors.

KW - Adenovirus vector

KW - Coronavirus

KW - IBV

KW - Infectious bronchitis virus

KW - S1

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84902182223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902182223&partnerID=8YFLogxK

U2 - 10.1637/10670-091913

DO - 10.1637/10670-091913

M3 - Article

C2 - 25055623

AN - SCOPUS:84902182223

VL - 58

SP - 211

EP - 215

JO - Avian Diseases

JF - Avian Diseases

SN - 0005-2086

IS - 2

ER -